tretazicar has been researched along with Adenocarcinoma in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ackerley, DF; Copp, JN; Patterson, AV; Prosser, GA; Smaill, JB; Syddall, SP; Williams, EM; Wilson, WR | 1 |
| Doshi, R; Green, NK; Kerr, DJ; McNeish, IA; Searle, PF; Young, LS | 1 |
| Anderson, CJ; Bilsland, AE; Evans, TR; Fletcher-Monaghan, AJ; Ganly, I; Keith, WN; Knox, RJ; McGregor, F; Plumb, JA | 1 |
| Green, NK; James, ND; Mautner, V; Searle, PF; Young, JG; Young, LS | 1 |
| Friedlos, F; Marais, R; Maycroft, KA; Paterson, H; Spooner, RA; Springer, CJ | 1 |
5 other study(ies) available for tretazicar and Adenocarcinoma
| Article | Year |
|---|---|
Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954.
Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Cell Survival; Colonic Neoplasms; Drug Screening Assays, Antitumor; Escherichia coli; Escherichia coli Proteins; Gene Silencing; Genetic Therapy; Humans; Kinetics; Nitroreductases; Prodrugs; SOS Response, Genetics; Transfection; Tumor Cells, Cultured | 2010 |
Immune enhancement of nitroreductase-induced cytotoxicity: studies using a bicistronic adenovirus vector.
Topics: Adenocarcinoma; Adenoviruses, Human; Adjuvants, Immunologic; Animals; Antineoplastic Agents, Alkylating; Aziridines; Bystander Effect; Colorectal Neoplasms; Combined Modality Therapy; Cytomegalovirus; Defective Viruses; Drug Resistance, Neoplasm; Escherichia coli Proteins; Female; Genes; Genes, Synthetic; Genetic Therapy; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunotherapy; Mesothelioma; Mice; Mice, Inbred BALB C; Neoplasm Transplantation; Nitroreductases; Prodrugs; Specific Pathogen-Free Organisms; Tumor Cells, Cultured | 2003 |
Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase.
Topics: Adenocarcinoma; Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Bacterial Proteins; Base Sequence; DNA-Binding Proteins; Drug Resistance, Neoplasm; Female; Genetic Therapy; Genetic Vectors; Humans; Male; Mice; Mice, Nude; Molecular Sequence Data; Neoplasms; Nitroreductases; Ovarian Neoplasms; Promoter Regions, Genetic; Telomerase; Tumor Cells, Cultured; Uterine Cervical Neoplasms | 2003 |
Combining gene and immunotherapy for prostate cancer.
Topics: Adenocarcinoma; Adenoviridae; Animals; Antineoplastic Agents; Aziridines; Biotransformation; Combined Modality Therapy; Defective Viruses; Escherichia coli Proteins; Genes, Synthetic; Genes, Transgenic, Suicide; Genetic Therapy; Genetic Vectors; Granulocyte-Macrophage Colony-Stimulating Factor; Immunotherapy; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Transplantation; Nitroreductases; Prodrugs; Prostatic Neoplasms; Recombinant Proteins; Specific Pathogen-Free Organisms | 2008 |
Appropriate subcellular localisation of prodrug-activating enzymes has important consequences for suicide gene therapy.
Topics: Adenocarcinoma; Antineoplastic Agents; Aziridines; Base Sequence; Breast Neoplasms; Cell Survival; Cloning, Molecular; Dimerization; Enzyme Activation; Escherichia coli; Female; Genetic Therapy; Humans; Molecular Sequence Data; Nitroreductases; Prodrugs; Recombinant Proteins; Restriction Mapping; Transfection; Tumor Cells, Cultured | 2001 |